Fake And Faulty Drugs: A Problem No One Wants To Talk About
A new book explores why getting a properly formulated medicine is hit-or-miss in much of the developing world — and why the issue is massively underreported.
Pharmacetuticals
Trump Drug Pricing 'Blueprint' Could Take Years To Build
The 39-page drug price plan includes an array of ideas that the administration will consider, but it's unclear which ones will be implemented.
Why Potentially Dodgy Diabetes Drugs Dominate in India
Indian drugmakers like to come up with combos — two meds in one pill. They can make more money that way. And they say it's easier for patients to take one pill than two. But is there a downside?
Rural Hospitals Struggle To Stock Expensive Drugs That Could Save Lives
A federal drug program blocks rural hospitals from getting discounts on rare-disease drugs, forcing staff to cut back on supplies of lifesaving medicines.
47 Hospitals Slashed Their Use Of Two Key Heart Drugs After Huge Price Hikes
These two older drugs, nitroprusside and isoproterenol, are frequently used in emergency and intensive care situations and have no direct alternatives, say cardiologists.
A Drugmaker Tries To Cash In On The Opioid Epidemic, One State Law At A Time
The maker of one medical treatment for opioid abuse has successfully lobbied statehouses around the country to pass policies that tilt addiction treatment practices in favor of the company's drug.
One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights
Some members of Congress say the U.S. government should use the patent rights it owns for any drugs that were developed with federal grants to drive down the prices of those drugs.
Dangers Of Opana Opioid Painkiller Outweigh Benefits, FDA Panel Says
Opana ER has been linked to an HIV outbreak in rural Indiana among people who abuse the opioid painkiller. An advisory panel to the Food and Drug Administration says the drug is too risky.
Patients Demand The 'Right To Try' Experimental Drugs, But Costs Can Be Steep
Terminally ill patients want easier access to candidate medicines still in the earliest stages of testing. While 33 states have passed laws to enable that, ethicists also warn of big risks.
Winners And Losers If 21st Century Cures Bill Becomes Law
Sweeping legislation that would reshape how the Food and Drug Administration reviews new products and bolster National Institutes of Health funding is moving closer to becoming law. What's at stake?